Blog
Feedback
schliessen

Filtern

 

Bibliotheken

Logo der Bibliothek

Logo FID Pharmazie PubPharm Discovery System Universitätsbibliothek Braunschweig Institut für Informationssysteme

Time to step up : A call to action for the clinical and quantitative pharmacology community to accelerate therapeutics for COVID-19

This article is protected by copyright. All rights reserved.

The global response to finding therapeutics for COVID-19 is chaotic even if well intentioned. There is an opportunity, but more importantly, an obligation for the global clinical and quantitative pharmacology community to come together and use our state-of-the-art tools and expertise to help society accelerate therapeutics to fight COVID-19. This brief commentary is a call to action and highlights how the global pharmacology community should contribute to the COVID-19 pandemic and prepare for future pandemics

Year of Publication: 2020
Contained in: Clinical and translational science (22.05.2020)
All journal articles: Search for all articles in this journal
Language: English
Contributors: Hartman, Dan | Author
Kern, Steven
Brown, Fran
Minton, Suzanne K
Rayner, Craig R
Full text access:
Electronic availability is being checked...
Links: Full Text (dx.doi.org)
Keywords: COVID-19
Journal Article
antiviral
chloroquine
clinical pharmacology
coronavirus
drug development
hydroxychloroquine
ivermectin
lopinavir
pandemic
ritonavir
ISSN: 1752-8062
Note: Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Notes: Date Revised 22.05.2020
published: Print-Electronic
Citation Status Publisher
Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Physical Description: Online-Ressource
ID (e.g. DOI, URN): 10.1111/cts.12824
more publication details ...

Associated Publications

  • Associated records are being queried...
more (+)
Internes Format
LEADER 02574nma a2200673 c 4500
001 NLM311110606
003 DE-601
005 20200522214427.0
007 cr uuu---uuuuu
008 200522s2020 000 0 eng d
024 7 |a 10.1111/cts.12824  |2 doi 
028 5 2 |a pubmed20n1208.xml 
035 |a (DE-599)NLM32441462 
040 |b ger  |c GBVCP 
041 0 |a eng 
100 1 |a Hartman, Dan 
245 1 0 |a Time to step up  |h Elektronische Ressource  |b A call to action for the clinical and quantitative pharmacology community to accelerate therapeutics for COVID-19 
300 |a Online-Ressource 
500 |a Date Revised 22.05.2020 
500 |a published: Print-Electronic 
500 |a Citation Status Publisher 
500 |a Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine 
520 |a This article is protected by copyright. All rights reserved. 
520 |a The global response to finding therapeutics for COVID-19 is chaotic even if well intentioned. There is an opportunity, but more importantly, an obligation for the global clinical and quantitative pharmacology community to come together and use our state-of-the-art tools and expertise to help society accelerate therapeutics to fight COVID-19. This brief commentary is a call to action and highlights how the global pharmacology community should contribute to the COVID-19 pandemic and prepare for future pandemics 
611 2 7 |a Journal Article  |2 gnd 
655 7 |a COVID-19  |2 gnd 
655 7 |a antiviral  |2 gnd 
655 7 |a chloroquine  |2 gnd 
655 7 |a clinical pharmacology  |2 gnd 
655 7 |a coronavirus  |2 gnd 
655 7 |a drug development  |2 gnd 
655 7 |a hydroxychloroquine  |2 gnd 
655 7 |a ivermectin  |2 gnd 
655 7 |a lopinavir  |2 gnd 
655 7 |a pandemic  |2 gnd 
655 7 |a ritonavir  |2 gnd 
689 0 0 |A f  |a Journal Article 
689 0 |5 DE-601 
689 1 0 |a COVID-19 
689 1 1 |a antiviral 
689 1 2 |a chloroquine 
689 1 3 |a clinical pharmacology 
689 1 4 |a coronavirus 
689 1 5 |a drug development 
689 1 6 |a hydroxychloroquine 
689 1 7 |a ivermectin 
689 1 8 |a lopinavir 
689 1 9 |a pandemic 
689 1 X |a ritonavir 
689 1 |5 DE-601 
700 1 |a Kern, Steven 
700 1 |a Brown, Fran 
700 1 |a Minton, Suzanne K 
700 1 |a Rayner, Craig R 
773 0 8 |i in  |t Clinical and translational science  |g  (22.05.2020)  |w (DE-601)NLM186391498  |x 1752-8062 
856 4 1 |u http://dx.doi.org/10.1111/cts.12824  |3 Volltext 
912 |a GBV_NLM 
951 |a AR 
952 |j 2020  |b 22  |c 05